The Dose

Welcome to The Dose, which tackles the finances behind local health care and life sciences and points to the most interesting national analysis. Your host is J.K. Wall.

Health Care & Life Sciences / Life Science & Biotech

WellPoint's respite from criticism will be short-lived

June 24, 2013
Comments Print Reprints
Share More
/ Text Size+

All holidays must come to an end. And America’s health insurers, including Indianapolis-based WellPoint Inc., should expect no different.

WellPoint and its peers have been enjoying a nice break from their long-running status as Public Enemy No. 1 in the nation’s health care debate. Recent attention has focused heavily on hospitals and doctors and the chaotic prices they charge.

As readers of The Dose know, I have made my own modest contribution to this shift in focus.

This shift has occurred, I believe, because the 2010 Patient Protection & Affordable Care Act put health insurers on a tighter leash, preventing them from engaging in their most controversial practices of the past.

No longer are insurers denying coverage for pre-existing conditions. When their premiums are now higher than 80 percent or 85 percent of medical claims, they refund the difference.

At the same time, health insurers have been able to keep premiums lower because health care costs have not been rising as fast as they had been—in fact, they even dropped in April, the first such dip since 1975. To no surprise, fewer families now report that they are struggling with medical bills.

Certainly hospitals deserve some credit for that trend—although most studies have credited either the slow-growing economy or the shift to high-deductible health plans.

Instead, with the health insurers on the sidelines, the main players left in the field to criticize have been the hospitals.

Right on cue, Steve Brill came out with his monumental article in Time magazine, which strung together a series of vivid anecdotes about how some hospitals—though certainly not all—aggressively mark up their services, taking advantage of the uninsured or those seriously ill with cancer.

Then came the Obama administration’s May release of Medicare data showing that hospital pricing varies wildly for no apparent reason. I have tried to explain how those variations came to be and, at the same time, how the data released is not terribly helpful.

Even the Healthcare Financial Management Association—the financial gurus working for hospitals and doctors—has now recognized the problem. HFMA announced the formation last week of a task force to address the issue of price transparency among its members.

“People want to know why health care costs what it does and what we’re doing about it,” said Joe Fifer, president of HFMA. “We need to move beyond the rhetoric.”

But I don't expect hopsitals to remain the public bad guys. It’s always easier to criticize the financier rather than the actual provider of services. That’s especially the case in health care, where hospitals and doctors literally save lives every day and health insurers have defined their job, as former WellPoint CEO Angela Braly once put it, as being the "disciplinarians" of the health care world. That will never make them popular, as Braly herself acknowledged.

As one case in point, WellPoint’s California subsidiary, Anthem Blue Cross, recently said it will raise premiums on small-business customers 11.5 percent next year. It blamed rising prices from health care providers.

In response, California Commissioner of Insurance Dave Jones said Anthem should be excluded from California’s newly created exchange for small-business health insurance policies.

"Anthem has engaged in a pattern of excessive and unjustifiable rate increases for its small employer customers and therefore they should not be permitted to participate in California's small employer health Exchange,” Jones said in a prepared statement.

The folks at WellPoint should expect California to be a harbinger of things to come.
 

ADVERTISEMENT
Comments powered by Disqus